Sunitinib 10-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2010 - Pain Management
View All Articles in Issue

Page(s): 248

Sunitinib 10-mg/mL Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Sunitinib 10-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, sunitinib, cancer chemotherapy, antineoplastic agent, anticancer treatment, receptor tyrosine kinase inhibitor

Related Categories: CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr	Mar/Apr 2004 Pg. 126-129
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 248
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr	Nov/Dec 2016 Pg. 510
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Sensitization Therapy for Warts Kuntz Rachael	Jul/Aug 2003 Pg. 266-270
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Cyclophosphamide 10-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 245